On: Monday, 4/22/24, at 5:00pm ET · Accession #: 1746473-24-59 · File #: 1-39303
Text Wildcards: ? (any letter/digit), * (many). Search Logic: for Documents: & (and), | (or); for Text: | (anywhere), "(&)" (near). Details...
Definitive Additional Proxy Soliciting Material — Schedule 14A — Rule 14a-12
Filing Table of Contents
Document/Exhibit Description Pages Size
1: DEFA14A Definitive Additional Proxy Soliciting Material HTML 11K
This is an HTML Document rendered as filed. [ Alternative Formats ]
C:
C:
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN
PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Check the appropriate box:
| | | | | |
☐ | Preliminary Proxy Statement |
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☐ | Definitive Proxy Statement |
☒ | Definitive Additional Materials |
☐ | Soliciting
Material Pursuant to §240.14a-12 |
Pliant Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box):
| | | | | | | | |
☒ | No fee required. |
☐ | Fee computed
on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
☐ | Fee paid previously with preliminary materials. |
↑Top
Filing Submission 0001746473-24-000059 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help —
Wed., May 15, 4:50:56.1pm ET